Healthcare -
Biotechnology - NASDAQ - US
$ 57.18
1.35 %
$ 7.27 B
Market Cap
18.93
P/E
HALO - CASH FROM OPERATIONS
Cash from Operations HALO - Halozyme Therapeutics, Inc.
389 M
LAST VALUE
13.91%
2 YEAR CAGR
58.01%
5 YEAR CAGR
25.73%
10 YEAR CAGR